Maverick Ventures

Maverick Ventures, established in 2015, operates as the dedicated venture capital arm of Maverick Capital, a globally recognised multi-billion dollar investment firm. Based in San Francisco, United States, the firm extends its investment reach across early-stage and growth-stage companies, with a pronounced focus on the transformative healthcare and technology sectors. Maverick Ventures distinguishes itself by combining the agility of a focused venture team with the extensive resources and esteemed reputation of its parent company, Maverick Capital. This integrated approach allows it to provide substantial capital and strategic guidance to its portfolio companies from their inception right through to initial public offerings and beyond.

The firm's investment philosophy is deeply rooted in identifying and partnering with exceptional founders who are at the forefront of healthcare innovation and enterprise artificial intelligence (AI) solutions. They seek out teams demonstrating profound technical expertise, astute business acumen, and an unwavering commitment to their vision. Maverick Ventures leverages an evergreen fund structure, a key differentiator that provides long-term, patient capital without the typical constraints of traditional fund lifecycles. This enables them to cultivate meaningful, enduring partnerships and offer sustained support throughout a company's developmental trajectory.

Maverick Ventures boasts a strong track record, having played a pivotal role in building 13 unicorns across its diverse portfolio of over 100 companies. The firm actively supports its portfolio companies through various mechanisms, including providing strategic resources like quantitative and data insights, leveraging deep AI networks, and connecting them with strategic limited partners, all designed to offer a technical and commercial advantage. In a notable development, Maverick Ventures raised a fourth fund of $240 million in March 2025, bringing its total assets under management for early-stage investments to over $1.4 billion.

The leadership team comprises experienced investors and operators. Lee Ainslie, the founder of Maverick Capital, provides macro oversight and strategic direction. Managing Partners David Singer and Ambar Bhattacharyya lead private investments, with Singer focusing on biotech and healthcare and Bhattacharyya on healthcare technology, digital health, and AI-driven healthcare. Other key team members include Managing Directors Lexi Henkel, Ryan Isono, and Prateesh Maheshwari, who bring a wealth of operational and sector-specific expertise from healthcare startups and major investment firms. Katherine Gomer serves as the Chief Operating Officer, ensuring the firm's operational excellence.